| Stage | NVDA | % of rev | AMKR | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $96.2B | 100.00% | $2.0B | 100.00% | NVDA ×48.34 |
| Gross profit | $72.1B | 74.98% | $364M | 18.26% | NVDA +56.7pp |
| Operating income | $63.7B | 66.24% | $225M | 11.29% | NVDA +54.9pp |
| Pre-tax income | $71.5B | 74.32% | $230M | 11.56% | NVDA +62.8pp |
| Net income | $59.7B | 62.03% | $191M | 9.59% | NVDA +52.4pp |
| Stage | NVDA | AMKR | Gap · A − B |
|---|---|---|---|
| Revenue | $96.2B100.00% | $2.0B100.00% | NVDA ×48.34 |
| Gross profit | 74.98%$72.1B | 18.26%$364M | NVDA +56.7pp |
| Operating income | 66.24%$63.7B | 11.29%$225M | NVDA +54.9pp |
| Pre-tax income | 74.32%$71.5B | 11.56%$230M | NVDA +62.8pp |
| Net income |
| 62.03%$59.7B |
| 9.59%$191M |
| NVDA +52.4pp |
No shared counterparties.